IL-22 Up-Regulates β-Defensin-2 Expression in Human Alveolar Epithelium via STAT3 but Not NF-κB Signaling Pathway

Inflammation

Volumn 38, Issue 3, 2015, Pages 1191-1200

  Li, Amin ^a   Gan, Yuying ^b   Wang, Ruikai ^a   Liu, Yanliang ^b   Ma, Ting ^b   Huang, Mao ^b   Cui, Xuefan ^b  

^a BENGBU MEDICAL COLLEGE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

A549 cells; human defensin 2; interleukin 22; signalling pathway

Indexed keywords

4-METHYL-N1-(3-PHENYLPROPYL)BENZENE-1,2-DIAMINE; ALPHA-CYANO-(3,4-DIHYDROXY)-N-BENZYLCINNAMIDE; BETA DEFENSIN; DEFB4A PROTEIN, HUMAN; DNA BINDING PROTEIN; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-22; MESSENGER RNA; PHENYLENEDIAMINE DERIVATIVE; RELA PROTEIN, HUMAN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR RELA; TYRPHOSTIN;

ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; EPITHELIUM CELL; HUMAN; IMMUNOLOGY; INFLAMMATION; LUNG ALVEOLUS; METABOLISM; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION;

BETA-DEFENSINS; CELL LINE; DNA-BINDING PROTEINS; EPITHELIAL CELLS; HUMANS; INFLAMMATION; INTERLEUKINS; PHENYLENEDIAMINES; PULMONARY ALVEOLI; RECEPTORS, INTERLEUKIN; RESPIRATORY MUCOSA; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TYRPHOSTINS;

EID: 84940007367     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0083-z     Document Type: Article

References (31)

1. Bartlett, J.A., A.J. Fischer, and P.B. McCray. 2008. Innate immune functions of the airway epithelium. Contributions to Microbiology 15: 147–163.
2. Hiemstra, P.S. 2007. The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Experimental Lung Research 33: 537–542.
3. Laube, D.M., S. Yim, L.K. Ryan, K.O. Kisich, and G. Diamond. 2006. Antimicrobial peptides in the airway. Current Topics in Microbiology and Immunology 306: 153–182.
4. Lai, Y., and R.L. Gallo. 2009. MPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends in Immunology 30: 131–141.
5. Yang, D., Z.H. Liu, P. Tewary, Q. Chen, G. de la Rosa, and J.J. Oppenheim. 2007. Defensin participation in innate and adaptive immunity. Current Pharmaceutical Design 13: 3131–3139.
6. McCormick, T.S., and A. Weinberg. 2010. Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontology 2000 54: 195–206.
7. Hollox, E.J., and J.A. Armour. 2008. Directional and balancing selection in human betadefensins. BMC Evolutionary Biology 8: 113.
8. Wehkamp, K., L. Schwichtenberg, J.M. Schröder, and J. Harder. 2006. Pseudomonas aeruginosa- and IL-1β-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. Journal of Investigative Dermatology 126: 121–127.
9. Kao, C.Y., Y. Chen, P. Thai, S. Wachi, F. Huang, C. Kim, et al. 2004. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways. Journal of Immunology 173: 3482–3491.
10. Yoon, Y.M., J.Y. Lee, D. Yoo, Y.S. Sim, Y.J. Kim, Y.K. Oh, et al. 2010. Bacteroides fragilis enterotoxin induces human beta-defensin-2 expression in intestinal epithelial cells via a mitogen-activated protein kinase/I kappaB kinase/NF-kappaB-dependent pathway. Infection and Immunity 78: 2024–2033.
11. Korn, T., E. Bettelli, M. Oukka, and V.K. Kuchroo. 2009. IL-17 and Th17 cells. Annual Review of Immunology 27: 485–517.
12. Aujla, S.J., and J.K. Kolls. 2009. IL-22: a critical mediator in mucosal host defense. Journal of Molecular Medicine 87: 451–454.
13. Aujla, S.J., Y.R. Chan, M. Zheng, M. Fei, D.J. Askew, D.A. Pociask, et al. 2008. IL-22 mediates mucosal host defense against gram-negative bacterial pneumonia. Nature Medicine 14: 275–281.
14. Kao, C.Y., C. Kim, F. Huang, and R. Wu. 2008. Requirements for two proximal NF-kappaB binding sites and IkappaB-zeta in IL-17A-induced human beta-defensin 2 expression by conducting airway epithelium. Journal of Biological Chemistry 283: 15309–15318.
15. Brand, S., F. Beigel, T. Olszak, K. Zitzmann, S.T. Eichhorst, J.M. Otte, et al. 2006. IL-22 is increased in active Crohn’s disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. American Journal of Physiology - Gastrointestinal and Liver Physiology 290: G827–G838.
16. Dumoutier, L., J. Louahed, and J.C. Renauld. 2000. Cloning and characterization of IL-10-related T cell derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. Journal of Immunology 164: 1814–1819.
17. Wolk, K., and R. Sabat. 2006. Interleukin-22: a novel T and NK cellderived cytokine that regulates the biology of tissue cells. Cytokine & Growth Factor Reviews 17: 367–380.
18. Wolk, K., S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat. 2004. IL-22 increases the innate immunity of tissues. Immunity 21: 241–254.
19. Sugimoto, K., A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, A.K. Bhan, et al. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. Journal of Clinical Investigation 118: 534–544.
20. Zheng, Y., P.A. Valdez, D.M. Danilenko, Y. Hu, S.M. Sa, Q. Gong, et al. 2008. Interleukin 22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Medicine 14: 282–289.
21. Wolk, K., E. Witte, K. Warszawska, G. Schulze-Tanzil, K. Witte, S. Philipp, et al. 2009. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. European Journal of Immunology 39: 3570–3581.
22. Ma, H.L., S. Liang, J. Li, L. Napierata, T. Brown, S. Benoit, et al. 2008. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. Journal of Clinical Investigation 118: 597–607.
23. Harder, J., U. Meyer-Hoffert, L.M. Teran, L. Schwichtenberg, J. Bartels, S. Maune, Mucoid, et al. 2000. Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. American Journal of Respiratory Cell and Molecular Biology 22: 714–721.
24. Mendez-Samperio, P., L. Alba, and A. Trejo. 2007. Mycobacterium bovismediated induction of human beta-defensin-2 in epithelial cells is controlled by intracellular calcium and p38MAPK. Journal of Infection 54: 469–474.
25. Rohrl, J., D. Yang, J.J. Oppenheim, and T. Hehlgans. 2010. Specific binding and chemotactic activity of mBD4 and its functional orthologue HBD2 to CCR6-expressing cells. Journal of Biological Chemistry 285: 7028–7034.
26. Zaiou, M. 2007. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. Journal of Molecular Medicine 85: 317–329.
27. Brogden, K.A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Reviews Microbiology 3: 238–250.
28. Cudic, M., and L. Otvos Jr. 2002. Intracellular targets of antibacterial peptides. Current Drug Targets 3: 101–106.
29. MacRedmond, R., C. Greene, C.C. Taggart, N. McElvaney, and S. O’Neill. 2005. Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide. Respiratory Research 6: 116.
30. Romano Carratelli, C., N. Mazzola, R. Paolillo, S. Sorrentino, and A. Rizzo. 2009. Toll-like receptor-4 (TLR4) mediates human beta-defensin-2 (HBD-2) induction in response to Chlamydia pneumoniae in mononuclear cells. FEMS Immunology and Medical Microbiology 57: 116–124.
31. Donnarumma, G., I. Paoletti, E. Buommino, M.R. Iovene, L. Tudisco, V. Cozza, et al. 2007. Anti-inflammatory effects of moxifloxacin and human beta-defensin 2 association in human lung epithelial cell line (A549) stimulated withlipopolysaccharide. Peptides 28: 2286–2292.